Results 31 to 40 of about 582,852 (293)

Pharmacological interactions of phosphate binders

Nefrología (English Edition), 2018
The use of phosphate binders is one of basic elements in the treatment of CKD-MBD (“Chronic Kidney Disease-Mineral and Bone Disorder”). It has been well known for decades that phosphate reten tion through direct and indirect mechanisms, contributes to the generation and progression of secondary hyperparathy roidism (SHP) and renal osteodystrophy in ...
Bover Sanjuan, Jordi, Navarro-Gonzalez, Juan Francisco, Arenas, M Dolores, Torregrosa, Jose-Vicente, Tamargo Menendez, Juan, de Francisco, Angel Luis Martin, Gonzalez-Parra, Emilio, Lloret Cora, M Jesus, Sanchez Alvarez, J Emilio, Martin-Malo, Alejandro, Molina Vila, Pablo, Bajo, M Auxiliadora, DaSilva Santos, Iara   +12 more
openaire   +3 more sources

Granulated organomineral fertilizers from by-products of the agricultural and forestry sector [PDF]

Scientia Agricola
The present study evaluated the granular properties of organomineral fertilizers produced from charcoal fines (biochar) and natural phosphate with three distinct binders: cassava wastewater (CW), pyroligneous extract (PE), and bio-oil (BO). The objective
José Mendes dos Santos Júnior, Fernando Colen, Leidivan Almeida Frazão, Rodinei Facco Pegoraro, Luiz Arnaldo Fernandes   +4 more
doaj   +1 more source

The incidence of hypercalcaemia in calcium-based phosphate binder groups.

, 2015
The incidence of hypercalcaemia in calcium-based phosphate binder groups.
Han Zhang (110653), Yuanhang Huang (709878), Zhiguo Mao (308723), Bo Yang (104813), Yong Wang (12837), Guoqiang Xie (308706)   +5 more
core   +1 more source

The incidences of drug intolerance in calcium-based phosphate binder groups.

, 2015
The incidences of drug intolerance in calcium-based phosphate binder groups.
Han Zhang (110653), Yuanhang Huang (709878), Zhiguo Mao (308723), Bo Yang (104813), Yong Wang (12837), Guoqiang Xie (308706)   +5 more
core   +1 more source

Hyperphosphatemia and phosphate binders: effectiveness and safety [PDF]

Current Medical Research and Opinion, 2013
In patients with kidney dysfunction hyperphosphatemia is more evident as renal failure progresses. It is related to increased FGF-23 levels, secondary hyperparathyroidism, and accelerated progressive vascular calcification. In CKD patients advanced coronary artery calcification is strongly associated with future cardiovascular events, cardiovascular ...
Rigas G, Kalaitzidis, Moses S, Elisaf
openaire   +2 more sources

Rank-heat plot of the phosphate binder network for laboratory outcomes.

, 2017
Rank-heat plot of the phosphate binder network for laboratory outcomes.
Alfonso Iorio (3215415), Jason W. Busse (34544), Nigar Sekercioglu (3215418), Lehana Thabane (17078), Noori Akhtar-Danesh (68830), Luciane Cruz Lopes (521867), Argie Angeliki Veroniki (3804550), Gordon H. Guyatt (34547)   +7 more
core   +1 more source

PA21, a New Iron-Based Noncalcium Phosphate Binder, Prevents Vascular Calcification in Chronic Renal Failure Rats [PDF]

, 2013
Chronic renal failure (CRF) is associated with the development of secondary hyperparathyroidism and vascular calcifications. We evaluated the efficacy of PA21, a new iron-based noncalcium phosphate binder, in controlling phosphocalcic disorders and ...
Phan, Olivier, Stehle, Jean-Christophe, Funk, Felix, Stehle, J.C., Burnier, Michel, Mordasini, D., Funk, F., Phan, O., Burnier, M., Maillard, Marc, Peregaux, C., Maillard, M., Mordasini, David, Peregaux, Christine, Funk F, Mordasini D, Maillard M, Burnier M, Peregaux C, Stehle JC, Phan O   +20 more
core   +1 more source

Effect of DFPP on Ferroptosis in Peripheral Blood CD14+ Monocytes of Hyperlipidemic Patients Involving the ACSL4/LPCAT3/ALOX5 Pathway

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Hyperlipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Although statins are the cornerstone of lipid‐lowering therapy, their use may be limited in some patients by adverse effects. This study evaluated the possible impact of non‐drug treatment using double‐filtration plasmapheresis (DFPP) on CD14+
Yun Cheng, Lan Li, Qingmei Yang, Meipeng Wu   +3 more
wiley   +1 more source

Characterization and evaluation of acid-modified starch of Dioscorea oppositifolia (Chinese yam) as a binder in chloroquine phosphate tablets

Brazilian Journal of Pharmaceutical Sciences, 2013
Chinese yam (Dioscorea oppositifolia) starch modified by acid hydrolysis was characterized and compared with native starch as a binder in chloroquine phosphate tablet formulations.
Adenike Okunlola, Oluwatomi Akingbala
doaj   +1 more source

Effect of Sevelamer on Calciprotein Particles in Hemodialysis Patients: The Sevelamer Versus Calcium to Reduce Fetuin-A-Containing Calciprotein Particles in Dialysis (SCaRF) Randomized Controlled Trial

Kidney International Reports, 2020
Introduction: Calciprotein particles (CPPs) are potentially modifiable mediators of phosphate toxicity in patients with kidney disease. We compared the effects of calcium carbonate (CC) and the non–calcium-based phosphate binder sevelamer on CPP levels ...
Edward R. Smith, Fei Fei M. Pan, Tim D. Hewitson, Nigel D. Toussaint, Stephen G. Holt   +4 more
doaj   +1 more source